Adma Biologics (ADMA) Preferred Shares (2011)

Adma Biologics' (ADMA) quarterly Preferred Shares came in at $8222.0 in Q4 2011.

Adma Biologics (ADMA) Preferred Shares (2011) Analysis & Trends

Adma Biologics (ADMA) has 1 years of Preferred Shares data on file, last reported at $8222.0 in Q4 2011.

Quarterly Preferred Shares changed N/A year-over-year to $8222.0 in Q4 2011, while the trailing twelve-month figure through Dec 2011 was $8222.0 (changed N/A YoY) and the FY2011 annual result came in at $8222.0, changed N/A from the prior year.
Preferred Shares steadied at $8222.0 in Q4 2011.
In the past five years, Preferred Shares ranged from a high of $8222.0 in Q4 2011 to a low of $8222.0 in Q4 2011.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Adma Biologics	2.13 Bn	2.00 Bn	86.28 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2011	8,222.00